Tag: Vaccine Transparency

In yesterday’s Part One , which you can read here, I looked at how the World Health Organization’s 2022 monkeypox public health emergency declaration prepared the ground for last week’s declaration.

AS IT transpires, repurposing MVA-BN from a smallpox vaccine to a monkeypox vaccine isn’t the only genius idea the vaccine mafia have had for repurposing what ought to be a redundant product.

It would seem that the real reason for the second monkeypox PHEIC is to facilitate large scale phase 3 testing of these mRNA vaccines. After all, ‘it’s an emergency’ – there have been nearly 14,000 cases. But what might be driving the increasing numbers of people suffering from the once rarely seen monkeypox? This is the question I will address in Part 2 of my report tomorrow